首页> 外文期刊>Acta Haematologica >A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.
【24h】

A rare case of chronic lymphocytic leukemia with hypercalcemia induced by elevated parathyroid hormone-related peptides.

机译:甲状旁腺激素相关肽升高引起的慢性淋巴细胞白血病伴高钙血症的罕见病例。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypercalcemia in malignancies is a frequent complication, mostly affecting patients with solid tumors or multiple myeloma. Calcium elevation is induced by direct bone infiltration of a tumor mass or through calcium liberation from the skeleton by a humoral mediator. The latter mechanism is referred to as humoral hypercalcemia of malignancy (HHM). Frequent mediators of HHM are parathyroid hormone-related peptides (PTHrP). We report a patient with chronic lymphocytic leukemia and hypercalcemia induced by PTHrP. In contrast to solid tumors and myeloma, PTHrP-induced HHM is very rare in low-grad lymphoma including chronic lymphocytic leukemia. Therapeutical approaches consist of cytoreductive treatment and calcium-lowering therapy with bisphosphonates.
机译:恶性肿瘤中的高钙血症是一种常见的并发症,主要影响实体瘤或多发性骨髓瘤的患者。钙的升高是由肿瘤块的直接骨浸润或通过体液介质从骨骼中释放钙引起的。后者的机制称为恶性体液性高钙血症(HHM)。 HHM的常见介体是甲状旁腺激素相关肽(PTHrP)。我们报道了由PTHrP引起的慢性淋巴细胞性白血病和高钙血症的患者。与实体瘤和骨髓瘤相反,PTHrP诱导的HHM在包括慢性淋巴细胞白血病在内的低级淋巴瘤中非常罕见。治疗方法包括细胞减少治疗和双膦酸盐降低钙的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号